Tests quality of life monitoring for people with lung cancer
Tests a patient-centered quality of life monitoring program for adults with lung cancer.
Plain-language title generated from the registry record
Registry title: Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring in Patients with Lung Cancer
Key facts
- Where
- Bamberg, Bayreuth, Coburg, Donaustauf, Kulmbach, Regensburg, and Straubing, GermanySee the 8 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a first diagnosis of lung cancer, at any stage, who are treated at one of six hospitals in Bavaria, Germany. It tests quality of life monitoring during routine follow-up care.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Primary lung cancer (ICD C33/C34), all stages. The tissue diagnosis (histology) must be no more than 2 months before joining.
Main reasons for not taking part
- Under 18 years old
- Pregnant or breastfeeding
- Unable to fill out the quality of life questionnaire (physical, psychological, cognitive or language reasons)
- Living outside the study region (Upper Palatinate, Lower Bavaria, Upper Franconia in Bavaria, Germany)
- Not a primary lung tumour diagnosis
Read by machine on 12 November 2026.
Where in Germany
- Klinikum BambergBamberg, GermanyContact: Rumo Leistner, MD, Dr.Taking people
- Hospital BayreuthBayreuth, GermanyContact: Alexander Kiani, MD, Prof.Taking people
- Klinikum Coburg GmbHCoburg, GermanyContact: Claus Steppert, MD, Dr.Taking people
- Caritas Krankenhaus St. Maria DonaustaufDonaustauf, GermanyContact: Maximilian Malfertheiner, MD, Prof.Taking people
- Klinikum KulmbachKulmbach, GermanyContact: Thomas Bohrer, MD, Prof.Taking people
- Krankenhaus Barmherzige BrüderRegensburg, GermanyContact: Hans-Stefan Hofmann, MD, Prof.Taking people
- Universitätsklinikum RegensburgRegensburg, GermanyContact: Hans-Stefan Hofmann, MD, Prof.Taking people
- Klinikum St. Elisabeth StraubingStraubing, GermanyContact: Jorge Fernando Gamarra, MD, Dr.Taking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Bayreuth
- Trial code
- NCT06252233
- Record updated
- 16 December 2024
- Original description
The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer during routine follow-up care.Read full original descriptionShow less
Improvement of Quality of Life (QoL) Using Preference-Oriented QoLMonitoring and Linkage with Clinical Registry Data: Randomised Clinical Trial in Patients with Lung Cancer
The purpose of the study is to determine whether a preference-oriented quality of life monitoring with defined diagnostic and therapeutic options improves quality of life in patients with lung cancer during routine follow-up care.
Inclusion: primary diagnosis of lung cancer (ICD C33/C34, all stages); treatment in one of six recruiting hospitals treating patients with lung cancer (University Hospital Regensburg, Hospital Barmherzige Brüder Regensburg, Hospital Bayreuth, Hospital Coburg, Hospital Kulmbach, Hospital Bamberg); difference between date of histology and date of study entry not exceeding 2 months; informed consent.
Exclusion: age under 18 years; unavailability of a study clinician for patient recruitment; patient misclassified in the candidate list (no primary diagnosis, no lung tumour); coordinating practitioner refuses trial participation; patient outside the defined study region (Germany, Bavaria: Upper Palatinate, Lower Bavaria, Upper Franconia); pregnancy/ breastfeeding; patient unable to fill out the QoL questionnaire (physical, psychological, cognitive, language reasons); patient refuses trial participation.